Search Results
Sep 09, 2026, 06:30 ET CURE ALZHEIMER'S FUND EXPANDS ITS SCIENTIFIC ADVISORY BOARD
and reinforces our commitment to identifying and funding the highest-impact Alzheimer's research," said Meg Smith, CEO of Cure Alzheimer's Fund. "The SAB's guidance helps ensure every research dollar is invested where it has the greatest potential to accelerate discoveries that lead to more effective treatments
More news about: Alzheimer's Disease Research Foundation
Nov 13, 2025, 02:14 ET Bioretec Ltd's business review January-September 2025: Strengthening commercial foundations and strategy design
reviewed ongoing and forthcoming clinical trials, product pipeline progress, and technology development. The Board members were also invited to follow the SAB's progress and support its work in advancing Bioretec's scientific and clinical objectives. New SAB
More news about: Bioretec
Nov 13, 2025, 02:10 ET Bioretec Ltd's business review January-September 2025: Strengthening commercial foundations and strategy design
reviewed ongoing and forthcoming clinical trials, product pipeline progress, and technology development. The Board members were also invited to follow the SAB's progress and support its work in advancing Bioretec's scientific and clinical objectives. New SAB
More news about: Bioretec
Nov 05, 2025, 13:41 ET Drug Hunter, Inc. Announces the Appointment of Dr. Lori Friedman, Ph.D., to its Scientific Advisory Board
and R&D leaders with the insights they need to discover tomorrow's medicines. Her deep expertise in biology and drug discovery complements the SAB's world-class knowledge as Drug Hunter grows its offerings across the spectrum of drug discovery disciplines.
More news about: Drug Hunter
Oct 21, 2025, 09:00 ET Brixton Biosciences Announces Scientific Advisory Board Leadership
The SAB's expertise will help Brixton Biosciences accelerate clinical development across multiple therapeutic areas, including osteoarthritis and post-surgical
More news about: Brixton Biosciences